Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Cirrhosis Portal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04197479
What this trial is testing

Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Madrigal Pharmaceuticals, Inc. 1,343
Testing effectiveness (Phase 2)UnknownNCT01728688
What this trial is testing

Safety and Efficacy of Human Autologous Peripheral Blood Stem Cells for Treatment of HBV-related Liver Cirrhosis

Who this might be right for
Liver CirrhosisEnd Stage Liver Disease
Air Force Military Medical University, China 240
Not applicableUnknownNCT03241823
What this trial is testing

Assessment of Patients With Hepatitis C Virus Related Liver Cirrhosis After Sustained Response to Direct Acting Anti Viral Drugs.

Who this might be right for
Hepatitis CLiver Cirrhosis
Assiut University 100
Not applicableLooking for participantsNCT07390344
What this trial is testing

VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS)

Who this might be right for
AscitesVariceal BleedingPortal Hypertension Related to Cirrhosis
W.L.Gore & Associates 152
Early research (Phase 1)Study completedNCT04971928
What this trial is testing

Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic Impairment

Who this might be right for
Hepatitis B
GlaxoSmithKline 24
Not applicableStudy completedNCT03884062
What this trial is testing

Clinical Impacts of Achieving SVR in Patients With Advanced Hepatic Fibrosis Related to Chronic HCV Treated With Direct Acting Antivirals

Who this might be right for
HCC in Chronic HCV Patients With Advanced Liver Fibrosis
Egyptian Liver Hospital 3,000
Large-scale testing (Phase 3)UnknownNCT01134692
What this trial is testing

Probiotics for Portal Hypertension

Who this might be right for
CirrhosisVarices, Esophageal
Govind Ballabh Pant Hospital
Not applicableLooking for participantsNCT07111221
What this trial is testing

Portal Inflow Modulation Prior to Liver Transplantation in Patients With Increased Risk of Intraoperative Blood Loss

Who this might be right for
Liver CirrhosisClinically Significant Portal Hypertension
Medical University of Warsaw 104
Post-approval studies (Phase 4)Study completedNCT01842581
What this trial is testing

The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyCirrhosis
Bausch Health Americas, Inc. 222
Not applicableEnded earlyNCT01846819
What this trial is testing

Factors Associated With End Stage Liver Disease

Who this might be right for
CirrhosisHepatic EncephalopathyFatigue+1 more
NYU Langone Health 27
Testing effectiveness (Phase 2)Ended earlyNCT04816916
What this trial is testing

Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
Axcella Health, Inc 12
Early research (Phase 1)Study completedNCT04634149
What this trial is testing

Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment

Who this might be right for
Moderate Liver ImpairmentSevere Liver Impairment
Bristol-Myers Squibb 16
Not applicableUnknownNCT05551884
What this trial is testing

Non-invasive Diagnosis of Portal Hypertension in Cirrhosis Based on Metabolomics Technology

Who this might be right for
Cirrhosis, LiverPortal Hypertension
Hepatopancreatobiliary Surgery Institute of Gansu Province 500
Not applicableWithdrawnNCT05817994
What this trial is testing

Endoscopic Ultrasound Guided Liver Biopsy and Portal Pressure Registry

Who this might be right for
Liver DiseasesLiver NeoplasmsLiver Dysfunction+3 more
Sheikh Shakhbout Medical City
Not applicableUnknownNCT05515861
What this trial is testing

Evaluation of EUS in Preventing Rebleeding After Endoscopic Cyanoacrylate Injection for Gastric Varices

Who this might be right for
Liver CirrhosisGastric VarixPortal Hypertension
Renmin Hospital of Wuhan University 150
Large-scale testing (Phase 3)Study completedNCT05511766
What this trial is testing

Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis

Who this might be right for
CirrhosisHepatic EncephalopathyAscites+2 more
Tanta University 150
Not applicableStudy completedNCT03804593
What this trial is testing

HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)

Who this might be right for
Cirrhosis, LiverHepatic CirrhosisHepatocellular Carcinoma+1 more
Epigenomics, Inc 175
Large-scale testing (Phase 3)UnknownNCT03720067
What this trial is testing

Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension

Who this might be right for
CirrhosisPortal HypertensionVariceal Hemorrhage
Universidade Federal do Rio de Janeiro 80
Not applicableStudy completedNCT03531593
What this trial is testing

Dose Effect Relationship of MTX and IBD

Who this might be right for
Inflammatory Bowel DiseasesLiver FibrosesMethotrexate
Children's Mercy Hospital Kansas City 64
Not applicableUnknownNCT04975490
What this trial is testing

Characterization and Pathogenesis of ACLF

Who this might be right for
Liver CirrhosisAcute-On-Chronic Liver FailurePortal Hypertension
Johann Wolfgang Goethe University Hospital 1,000
Next Page